Table 1.
Characteristics of study population
| M | F | M + F | |
|---|---|---|---|
| Total sample, n (%) | 98 (69.0) | 44 (31.0) | 142 |
| Age (years), mean (SD) | 12.6 (3.0) | 11.4 (2.7) | 12.2 (2.9) |
| Age group (years), n (column %) | |||
| 4–6 | 5 (5.1) | 3 (6.8) | 8 (5.6) |
| 7–9 | 9 (9.2) | 7 (15.9) | 16 (11.3) |
| 10–12 | 28 (28.6) | 20 (45.5) | 48 (33.8) |
| 13–15 | 41 (41.8) | 12 (27.3) | 53 (37.3) |
| 16–18 | 15 (15.3) | 2 (4.5) | 17 (12.0) |
| Age at diagnosis (years), mean (SD) | 8.3 (3.6) | 6.9 (3.5) | 7.9 (3.6) |
| Age at first signs and symptoms (years), mean (SD) | 5.8 (4.1) | 5.6 (3.5) | 5.7 (3.9) |
| Years of treatment, mean (SD) | 4.3 (3.2) | 4.5 (3.6) | 4.4 (3.3) |
| Geographical area, n (column %) | |||
| Northwest | 45 (45.9) | 20 (45.5) | 65 (45.8) |
| Northeast | – | 2 (4.6) | 2 (1.4) |
| Centre | 4 (4.1) | – | 4 (2.8) |
| South and major islands | 49 (50.0) | 22 (50.0) | 71 (50.0) |